project . 2002 - 2004 . Closed

Development of novel would healing therapies.

Wellcome Trust
  • Funder: Wellcome TrustProject code: 068906
  • Funded under: Innovations Funder Contribution: 587,368 GBP
  • Status: Closed
  • Start Date
    01 Oct 2002
    End Date
    31 Mar 2004
Description
The potential Development Funding is focused on clinical development of the lead product TranCell-S, and its second and third generation versions, TranCell-S II and TranCell-S III. The proposal is divided into four parts: Further clinical evaluation of the first product, TranCell-S Development of a clinical protocol for regulatory approval of TranCell-S In vitro development of TranCell-S II, including development of serum free culture conditions Development of plasma polymerised surfaces to which fragments of MSH have been immobilised TranCell-S is currently undergoing three proof of concept clinical trials. These are for non-healing diabetic foot ulcers (six pa...
Description
The potential Development Funding is focused on clinical development of the lead product TranCell-S, and its second and third generation versions, TranCell-S II and TranCell-S III. The proposal is divided into four parts: Further clinical evaluation of the first product, TranCell-S Development of a clinical protocol for regulatory approval of TranCell-S In vitro development of TranCell-S II, including development of serum free culture conditions Development of plasma polymerised surfaces to which fragments of MSH have been immobilised TranCell-S is currently undergoing three proof of concept clinical trials. These are for non-healing diabetic foot ulcers (six pa...
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue